| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0047 | 1 |